Clinical Trials Logo

Clinical Trial Summary

This study aims to determine the effect of an acute maximal exercise on serum uncoupling protein-1, irisin, interleukin 6 levels, and on blood lipid and lipoprotein concentrations. This study also evaluates the role of uncoupling protein-1-3826 A/G polymorphism on this eventual effect.

Therefore, this study hypothesizes that:

H01: Sedentary people and athletes' serum uncoupling protein 1, irisin, and interleukine 6 levels are different before and after an acute maximal exercise.

H02: Sedentary people and athletes' basal serum uncoupling protein 1 levels are associated with uncoupling protein 1-3826 A/G polymorphism.

H03: Uncoupling protein 1-3826 A/G polymorphism has a modifying role in the effect of maximal exercise on serum uncoupling protein 1 levels.

H04: Sedentary people and athletes' basal serum lipid and lipoprotein levels are associated with uncoupling protein 1-3826 A/G polymorphism.

H05: Uncoupling protein 1-3826 A / G polymorphism has a modifying role in the effect of maximal exercise on serum lipid and lipoprotein levels.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04156113
Study type Interventional
Source Eastern Mediterranean University
Contact
Status Completed
Phase N/A
Start date November 11, 2019
Completion date September 7, 2020

See also
  Status Clinical Trial Phase
Completed NCT04298346 - Neurological Fate, Prematurity and Genetic Susceptibility Factors
Completed NCT04806971 - Vitamin D Receptor, Interleukin-1A and Interleukin-1B Gene Polymorphisms in Periodontitis
Completed NCT04077554 - Relationship Between the VEGF Gene Polymorphism and Cardiometabolic Risk Factors
Recruiting NCT05750732 - Weight Loss and CLOCK 3111T/C Polymorphism